09-14-2017 12:20 PM CET - Health & Medicine
Print

Download India Cervical Cancer Screening Market Outlook 2022 Report

Press release from: Kuick Resarch

Cervical cancer is an important area of action for any cancer control programme because of the burden of disease, and the potential for effective prevention through screening. Cervical cancer hardly presents any symptoms in its early stages and it highlights the importance of regular screening for the disease. Screening is looking for cancer before a person has any symptoms. This can help to find the cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat.

Screening programs involve the testing of asymptomatic individuals with a precise screening test to identify those who likely to have the disease of interest and for the further investigation to confirm or exclude the disease. The aim of cancer screening is to prevent the cancer deaths and to improve the quality of life by finding cancers in early stage and by effectively treating them.

A choice to familiarize a screening program in public health services depends on the evidence that the benefits overshadow the harms of screening, disease burden, availability of suitable screening test, effective treatment, adequate resources, and efficient health services. Screening programs should achieve high participation for testing, diagnosis, and treatment. The population based cervical cancer screening programs have not yet been executed in many of the developing countries, despite the fact that cervical cancer has the greatest burden in developing countries, which is largely related to poverty, lack of resources and infrastructure and disqualification of women.

India accounts for 25% of global cervical incidences and death in annually in India. At present Women population accounts for approximately 49% of total Indian population. Among the total female population base, urban woman appears to be much aware of cervical screening test as compared to rural counterparts. Currently, there are VIA and Pap Smear test most common for cervical screening, but have their own disadvantages like inconvenience and less predictive and more confirmatory and surgical in nature.

Cervical cancer screening market in India is in still infancy stage. Currently the market is highly unorganized in the nature as most of the screening tests are performed in hospitals or under public programmes. The demand for cervical cancer screening is expected to rise with increasing awareness and growing concerns regarding second most common type of cancer causing large number of deaths among women in the country. The current degree of competition in terms of cervical screening in Indian is minimal with the availability of 2-3 players in the market.

There exist ample unexplored opportunity for various stake holders of the cervical screening market in India. Currently there is no big player in the market having national or regional level reach in Indian market. The entry restraints are minimal except the initial level of investment required to setup the operations. The large female population base serve as the untapped market potential along with the expansion growth opportunities in the future.

“India Cervical Cancer Screening Market Outlook 2022” research report discusses all aspects related to the cervical cancer screening market in India. Report gives comprehensive insight on the current accessible cervical screening approaches available in India. The various market dynamics discussed in the report offers unexplored opportunity for all stakeholders involved in the industry to expand their operations in Indian cervical screening market.

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:www.kuickresearch.com/report-india-cervical-cancer-screen...

Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4

Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
2.2 Prevalence of Cervical Cancer in India
2.3 Existence of the Cervical Cancer around the World

Risk Factors for Cervical Cancer
3.1 Reasons for High Cervical Cancer Frequencies
3.2 Rural v/s Urban Cervical Cancer Risk Trends

Cervical Cancer Screening in India
4.1 Accessible Screening Approaches in India
4.1.1 Pap smear Method
4.1.2 Liquid Based Cytology Method
4.1.3 Visual Inspection with the Acetic Acid (VIA)
4.1.4 HPV DNA Test
4.2 Screening for Cervical Cancer in Developing Countries
4.3 Cervical Cancer Screening Kits
4.3.1 VIRO-Safe Screening Kit
4.3.2 The Digene Hc2 High Risk HPV DNA Test Kit
4.3.3 Magnivisualizer Detecting Device


Therapeutics Strategies for the Treatment of Cervical Cancer
5.1 Surgery
5.1.1 Hysterectomy
5.1.2 Pelvic Exenteration
5.1.3 Radical hysterectomy
5.1.4 Conization
5.1.5 Trachelectomy
5.2 Radiotherapy
5.2.1 External Beam Radiation Therapy (EBRT)
5.2.2 Branchytherapy
5.3 Chemotherapy

HPV Vaccination in India
6.1 Introduction
6.2 Efficacy of the HPV Vaccine
6.3 Cost of HPV Vaccine for Developed and Developing Countries

Vaccination Programs by the Indian Government

Available HPV Vaccines in India
8.1 Quadrivalent Vaccine: - Gardasil
8.2 Bivalent Vaccine: - Cervarix

India Cervical Cancer Vaccines Market Analysis
9.1 India v/s Other Markets of Cervical Cancer Vaccine
9.2 Cervical Cancer Vaccine Market in India

HPV Vaccines Market Dynamics
10.1 Favorable Market Parameters
10.2 Challenges to the Development and Commercialization of HPV Vaccine

India Cervical Cancer Screening Market Future Prospects

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Kuick Research
New Delhi - 110001
India
+91-11-47067990

This release was published on openPR.
News-ID: 716904 • Views: 72
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: